GOLDMAN SACHS GROUP INC - COLUCID PHARMACEUTICALS INC ownership

COLUCID PHARMACEUTICALS INC's ticker is CLCD and the CUSIP is 19716T101. A total of 20 filers reported holding COLUCID PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of COLUCID PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2016$597,000
+929.3%
16,404
+9.7%
0.00%
Q3 2015$58,00014,9550.00%
Other shareholders
COLUCID PHARMACEUTICALS INC shareholders Q3 2015
NameSharesValueWeighting ↓
Novo Holdings A/S 3,056,563$11,829,0001.22%
SPHERA FUNDS MANAGEMENT LTD. 317,250$1,228,0000.16%
PIPER SANDLER & CO. 5,215$20,0000.02%
Pentwater Capital Management LP 483,686$1,872,0000.02%
MPM ASSET MANAGEMENT LLC 21,806$84,0000.01%
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 100,794$390,000,0000.01%
VANGUARD GROUP INC 4,540,091$161,209,0000.01%
Tower Research Capital LLC (TRC) 11,555$45,0000.00%
PRICE T ROWE ASSOCIATES INC /MD/ 1,355,835$5,247,0000.00%
PANAGORA ASSET MANAGEMENT INC 31,891$123,0000.00%
View complete list of COLUCID PHARMACEUTICALS INC shareholders